Asimadoline
Asimadoline is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and has the potential for treating other gastrointestinal diseases.
Product Specifications
CAS Number
153205-46-0
Product Name Alternative
Asimadoline
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 103.3 mg/mL; 249.19 mM
Smiles
CN ([C@H] (CN1CC[C@@H] (C1) O) C2=CC=CC=C2) C (=O) C (C3=CC=CC=C3) C4=CC=CC=C4
Molecular Formula
C27H30N2O2
Molecular Weight
414.54
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Benzeneacetamide, N- ((1S) -2- ((3S) -3-hydroxy-1-pyrrolidinyl) -1-phenylethyl) -N-methyl-alpha-phenyl-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Lysophosphatidic Acid Receptor 3 (LPAR3) ELISA Kit
Pde8b Mouse shRNA Lentiviral Particle (Locus ID 218461)
(2S,3S) -2-Amino-N,3-dimethylpentanamide hydrochloride
(2S,3S) -2-Amino-N,3-dimethylpentanamide hydrochloride